Puma Biotechnology, Inc. (PBYI) cotiza a un P/E histórico de 12.1, P/E futuro de 29.9. El rendimiento de ganancias histórico es 8.29%, rendimiento de ganancias futuro 3.34%. El Número de Graham es $6.00.
Criterios demostrados por esta página:
Puntuación General SharesGrow: 69/100 con 4/7 criterios aprobados.
| Year | P/E (TTM) | Ratio PEG | Ratio P/B | Ratio P/S | Rendimiento por Dividendo |
|---|---|---|---|---|---|
| 2016 | -3.7 | -0.33 | 4.87 | 0.00 | - |
| 2017 | -12.6 | 2.43 | 68.93 | 132.64 | - |
| 2018 | -6.8 | 0.11 | 22.51 | 3.08 | - |
| 2019 | -4.5 | 0.16 | 19.43 | 1.25 | - |
| 2020 | -6.8 | 0.24 | -68.23 | 1.80 | - |
| 2021 | -4.2 | 0.08 | -50.51 | 0.49 | - |
| 2022 | 94,486.6 | -918.83 | 8.75 | 0.83 | - |
| 2023 | 9.5 | 0.00 | 3.82 | 0.87 | - |
| 2024 | 4.9 | 0.14 | 1.61 | 0.64 | - |
| 2025 | 9.6 | 0.00 | 2.28 | 1.30 | - |
| Year | EPS (Diluido) | Ingresos | Ingreso Neto | Margen Neto |
|---|---|---|---|---|
| 2016 | $-8.29 | $0.00 | $-276M | - |
| 2017 | $-7.86 | $27.7M | $-292M | -1054.2% |
| 2018 | $-2.99 | $251M | $-113.6M | -45.3% |
| 2019 | $-2.13 | $272.3M | $-82.72M | -30.4% |
| 2020 | $-1.52 | $225.1M | $-60M | -26.7% |
| 2021 | $-0.72 | $253.2M | $-29.1M | -11.5% |
| 2022 | $0.02 | $228M | $912K | 0.4% |
| 2023 | $0.45 | $235.64M | $21.59M | 9.2% |
| 2024 | $0.62 | $230.47M | $30.28M | 13.1% |
| 2025 | $0.61 | $228.37M | $31.11M | 13.6% |
| Year | EPS (Prom.) | Rango EPS | Ingresos (Prom.) | Rango de Ingresos | Analistas |
|---|---|---|---|---|---|
| 2026 | $0.25 | $0.21 – $0.29 | $218M | $218M – $218M | 1 |
| 2027 | $0.50 | $0.49 – $0.51 | $218M | $218M – $218M | 1 |
| 2028 | $0.45 | $0.45 – $0.45 | $218M | $218M – $218M | 1 |
| 2029 | $0.35 | $0.35 – $0.35 | $217M | $217M – $217M | 1 |
| 2030 | $0.20 | $0.20 – $0.20 | $216M | $216M – $216M | 1 |
